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Abstract The storage of xenobiotic compounds as 
glycerolipids and their subsequent mobilization was studied 
using fenbufen and differentiated 3T3-Ll cells in culture. 
Fenbufen was taken up from the incubation medium and 
incorporated into triacylglycerol, diacylglycerol, and phos- 
pholipids. The triacylglycerol was susceptible to digestion by 
pancreatic lipase. The xenobiotic phospholipid contained 
three species, one of which behaved as fenbufenoyl phospha- 
tidylcholine as judged by TLC, HPLC, choline analysis, and 
mass spectroscopy. After incubation with radioactive fen- 
bufen for 18 h, the cells were transferred to a chase medium 
where radioactivity was lost from the cells and appeared in 
the medium. The rate was three times higher when 10 PM 
isoproterenol was present; insulin had no effect. Nonesteri- 
fied fenbufen and analogues of mono- and di-acylglycerol 
were secreted. Monofenbufenoylglycerol was characterized 
by its ability to be used as a substrate by purified monoacyl- 
glycerol acyltransferase. When oleic acid was used in place of 
fenbufen, the majority of the radioactivity released in a chase 
experiment was the nonesterified acid (over 90%) and nei- 
ther mono- nor di-acylglycerol was detected.l These data in- 
dicate that 3T3-Ll adipocytes can synthesize fenbufencon- 
taining lipids and release them into the medium on hormonal 
stimulation. The secretion of mono- and di-acylglycerols may 
have unforeseen pharmacological or toxicological implica- 
tions.-Dodds, P. F., S-C. Chou, A. Ranasinghe, and R A. 
Coleman. Metabolism of fenbufen by cultured 3T3-Ll adipo- 
cytes: synthesis and metabolism of xenobiotic glycerolipids.]. 
Lipid Res. 1995. 36: 2493-2503. 
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Xenobiotic glycerolipids are synthesized when a xeno- 
biotic carboxylic acid, which may be a drug, an agro- 
chemical, a food additive, a pollutant, or some other 
foreign compound, becomes esterified to the glycerol 
backbone of a lipid in place of a natural fatty acid. Over 
35 different xenobiotic acids are now known to form 
such conjugates, the most common of which are ana- 
logues of triacylglycerols and diacylglycerols. The forma- 
tion of xenobiotic phospholipids has not been well 
demonstrated except when the structure of the xenobi- 
otic acid is very similar to that of a fatty acid (1-4). 
Aside from the interest to lipid biochemists in what 
the synthesis of xenobiotic lipids tells us about the 
specificity of the acyltransferases involved, there is a 
natural concern about the possible toxic implications of 
their formation. Fears have been expressed that incor- 
poration of xenobiotic phospholipids may disrupt mem- 
brane function (5) ,  and that xenobiotic diacylglycerols 
may behave like the tumor-promoting phorbol diesters 
(6). Perhaps more importantly, incorporation into xeno- 
biotic lipids represents a mechanism by which poten- 
tially toxic compounds may be retained in the body and 
accumulate over a period of prolonged, albeit low, 
exposure. The logical corollary of such storage is that 
the compound may be released later, as a result of 
dietary or hormonal change, in concentrations higher 
than those experienced during the initial exposure. 
More is known about the formation of xenobiotic 
lipids than is known about their degradation. Both 
experiments in vivo (7-10) and those performed with 
individual lipases (6, 11-13) suggest that xenobiotic 
acylglycerols may be less readily mobilized than either 
natural acylglycerols or non-lipophilic xenobiotic conju- 
gates. 
In order to understand the metabolism of xenobiotic 
acids in adipose tissue, a primary storage site for xeno- 
biotic glycerolipids, we studied the incorporation and 
mobilization of fenbufen [4(4biphenyl)4~xo-butanoic 
Abbreviations: TLC, thin-layer chromatography; HPLC, high 
performance liquid chromatography; FAB, fast atom bombardment; 
MS, mass spectroscopy; DMEM, Dulbecco's minimum essential 
medium. 
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acid], a non-steroidal anti-inflammatory drug, by cul- 
tured 3T3-Ll cells. These 3T3-Ll fibroblasts can differ- 
entiate into adipocytes, synthesize and store triacyl- 
glycerol, and respond to hormones such as insulin and 
epinephrine (14-18). We present evidence that fen- 
bufen can be incorporated into a variety of xenobiotic 
glycerolipids by 3T3-Ll cells, and can be mobilized in 
response to a lipolytic stimulus. 
EXPERIMENTAL PROCEDURES 
Materials 
[ring-U-14C]fenbufen was obtained from Amersham 
North America (Arlington Heights, IL) and dissolved in 
95% (w/v) ethanol. The fenbufen was confirmed to be 
98% radiochemically pure by thin-layer chromatogra- 
phy in chloroform-methanol-acetic acid 95:5:5 (v/v) on 
silica gel G. [l-14C]oleic acid was obtained from ICN 
Biomedicals Inc. (Costa Mesa, CA). Fenbufen, methyl 
isobutylxanthine, dexamethasone, insulin, pancreatic li- 
pase Type VI-S (triacylglycerol acylhydrolase; EC 
3.1.1.3), and (*)-isoproterenol hydrochloride were ob- 
tained from Sigma Chemical Corporation, St. Louis, 
MO. 4Biphenyl acetate was obtained from Aldrich 
Chemical Company Inc. (Milwaukee, WI). Lipid stand- 
ards for TLC (oleic acid forms), and dipalmitoyl-, di- 
oleoyl-, and ddinoleoyl-phosphatidylcholines for HPLC 
were obtained from Serdary Research Laboratories Inc., 
London, Ontario. All other chemicals were reagent 
grade. Thin-layer chromatography plates were from 
Analtech, Newark, DE, from Merck Ltd., Poole, U.K. 
(silica gel F254 plates), or from Whatman International 
Ltd., Maidstone, U.K. (Linear-K preparative plates). Tis- 
sue culture supplies were obtained from the Lineberger 
Cancer Center, UNC. 
sn-1,3-Dipalmitoyl-2-fenbufenoyl-glycerol was made 
by Merlin Synthesis, Wye College, Wye, Ashford, U.K. 
by reacting sn-l,3dipalmitoylglycerol with fenbufen in 
the presence of dicyclohexylcarbodiimide. The struc- 
ture was confirmed by proton NMR. A sample of the 
product was converted to the corresponding sn-2-fen- 
bufenoyl-glycerol by incubating with pancreatic lipase as 
described below. sn-l-Acyl-2-fenbufenoyl-glycerophos- 
phocholine (fenbufenoyl-phosphatidylcholine) was pre- 
pared by reacting lysophosphatidylcholine (from egg; 
Lipid Products, Redhill, Surrey, U.K.) with fenbufen in 
the presence of N,N-carbonyldiimidazole (19). The 
product was purified by TLC on a 1-mm thick “Linear-K” 
silica gel plate developed in chloroform-metha- 
nol-water 25:lO:l (v/v). The identity of the product was 
confirmed by fast atom bombardment (FAB)-mass spec- 
troscopy (MS) carried out in the Chemistry Department, 
Kings College, University of London, U.K. The product 
showed a mass ion with a m/z equal to 236 more than 
the lysophosphatidylcholine precursor corresponding 
to the addition of one molecule of fenbufen and the loss 
of one molecule of water on esterification. 
CeIl culture 
3T3-Ll cells, obtained from the American Type Tis- 
sue Culture Collection, were grown to confluence in 
60-mm dishes in Dulbecco’s minimum essential medium 
(DMEM) containing 10% fetal bovine serum and peni- 
cillin and streptomycin (standard culture medium) (15). 
Cells were differentiated at confluence by replacing the 
culture medium with the same medium supplemented 
with 0.25 ~ L M  dexamethasone, 0.5 mM methyl isobutyl- 
xanthine, and 10 pg/ml (equal to 1.7 pM) insulin. After 
48 h the medium was again replaced with standard 
culture medium supplemented only with 10 pg/ml in- 
sulin. Medium was changed every 48 hand the cells were 
used for experiments 5 days after removal of methyl 
isobutylxanthine and dexamethasone when approxi- 
mately 80% of the cells contained lipid droplets. 
Individual 60-mm dishes of differentiated 3T3-Ll 
adipocytes were incubated at 37°C in 2 ml of standard 
culture medium to which 5 p1 of ethanol containing 
[I4C]fenbufen had been added (yielding a concentration 
in the medium of 26.9 pM fenbufen, 13.2 pCi/pmol). 
Cells were then either washed and extracted or incu- 
bated with ‘chase medium’ as described in the legend to 
Fig. 5. 
Extraction of lipid products 
Floating cells and debris were removed from the 
medium by sedimenting at 1200 g for 5 min at room 
temperature in a bench centrifuge. Aliquots (100 pl) 
were counted. A larger sample (800 pl) was acidified 
with 10 ~ 1 6 0 %  perchloric acid and extracted with 3 ml 
chloroform-methanol 1:2 (v/v). Chloroform (1 ml) and 
water (1 ml) were added. After vortexing, the phases 
were separated in a bench centrifuge at 1200gfor 5 min. 
Aliquots of each phase (100 p1 of the upper phase and 
50 pl of the lower phase) were counted. 
To collect the cells, 1 ml ice-cold methanol was added 
to each dish. Cells were scraped with a rubber policeman 
and transferred to centrifuge tubes. The process was 
repeated with a further 1 ml methanol and then with 0.5 
ml water. Chloroform (1 ml) was added to each pooled 
suspension and the tubes were vortexed. After at least 
4 h at -2O”C, the cellular debris was sedimented at 1200 g 
for 5 min in a bench centrifuge and the supernatant was 
collected. The pellet was re-extracted in 1.875 ml chlo- 
roform-methanol 1:2 (v/v) plus 0.5 ml water. The su- 
pernatants from the first and second extractions were 
pooled and 1.625 ml chloroform and 1.925 ml water 
were added. After mixing, the phases were separated in 
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a bench centrifuge at 1200 g for 5 min. Samples of the 
upper aqueous phase (100 pl) and lower chloroform 
phase (50 pl) were counted. 
Thin-layer chromatography 
Aliquots of the chloroform phases of cell (0.5 ml) and 
media extracts (1.0 ml) were dried using a SpeedVac 
concentrator (Savant, Hicksville, NY). Each residue was 
redissolved in 20 pl chloroform-methanol1:2 (v/v) and 
applied to one lane of a silica gel G plate; each tube was 
washed twice with further 20-pl aliquots of the same 
solvent which were applied to the same lane of the TLC 
plate. Because fenbufen did not migrate adequately in 
systems designed to separate neutral glycerolipids, the 
plates were developed in Solvent System 1, chloro- 
form-methanol-acetic acid 100:2.5:5 (v/v). In this sys- 
tem, fenbufen had an Rf of about 0.8; phospholipid 
standards migrated up to 1 cm from the origin but were 
well separated from monooleoyl- and monofen- 
bufenoylglycerol standards. As with some other non- 
standard solvent systems (20, 2 1) diacylglycerols mi- 
grated between triacylglycerol and fatty acid (see Fig. l). 
After development, the plates were scanned by a Bio- 
Scan 200 system (BioScan, Washington, DC) and the 
relative sizes of the radioactive peaks were determined 
after integration of the resulting trace. The accuracy of 
the integration method was confirmed initially by scrap- 
ing silica from the TLC plate followed by liquid scintil- 
lation counting. 
When it was necessary to retard fenbufen and possible 
acidic metabolites at the origin, the TLC plate was 
developed in chlorofonn-methanol-methylamine 
100:2.5:0.5 (v/v) (Solvent System 2). 
In order to separate phospholipid products, the TLC 
was developed either in acidic systems of chlorofonn- 
methanol-acetone-acetic acid-water 30: 10:40: 10:5 
(v/v) (Solvent System 3), or in the more polar chloro- 
form-methanol-acetic acid-water 60:40:9:3 (v/v) (Sol- 
vent System 4), or in basic systems of chloroform- 
methanol-ammonia 65:25:5 (v/v) or 50:40:5 (v/v) (Sol- 
vent Systems 5 and 6, respectively). 
Identification of products 
The band that was identified by co-chromatography 
with a known standard as fenbufenoyl-triacylglycerol (in 
which at least one of the fatty acids was replaced by 
fenbufen) was scraped from the TLC plate and extracted 
in chloroform-methanol 1 :2 (v/v). Solvent was removed 
in a centrifugal concentrator and the lipid was sonicated 
in 0.75 M Tis, pH 7.4, 0.167 M CaClz, 0.167% (w/v) 
anhydrous sodium taurocholate. To 1.2 ml of the emul- 
sion was added 1000 units of pancreatic lipase Type 
VIS. Samples of the mixture were removed within 1 min 
after the enzyme was added and after 40 min incubation 
at room temperature. These samples were extracted 
three times with 2.5 ml diethyl ether. The extracts were 
combined, then dried, chromatographed in Solvent Sys- 
tem 1, and scanned as described above. 
The radiolabeled band identified by co-chromatogra- 
phy as monofenbufenoyl-glycerol was scraped from 
plates, extracted with chloroform-methanol 1:2 (v/v), 
and dried in a centrifugal concentrator. This extracted 
monofenbufenoyl-glycerol was incubated with 0.2 mM 
palmitoyl-CoA and monoacylglycerol acyltransferase 
(EC 2.3.1.22), partially purified from the livers of 1 l-day- 
old rats to the stage after chromatography on hydroxyl- 
apatite (22). After 0 or 60 min incubation at 23"C, 
samples of the reaction mixture were extracted into 
heptane (23). The extracts were dried, chromatogra- 
phed on silica gel G plates in Solvent System 1, and 
scanned as described above. 
In order to identify the radiolabeled compound that 
cwhromatographed with phosphatidylcholine, each of 
ten 100-mm dishes of differentiated 3T3-Ll adipocytes 
was incubated for 21 h with DMEM containing 10% fetal 
bovine serum, penicillin, streptomycin (15), and 
[14C]fenbufen (0.50 pCi/pmol) added in 2.5 pl of etha- 
nol per ml of medium to give a final concentration of 
41.6 pM. The cells were extracted as described above but 
in double the volumes. The combined extracts were 
concentrated and applied to a TLC plate that was devel- 
oped in Solvent System 3. Because scanning revealed 
that the plate was overloaded with extracted triacyl- 
glycerol, the lower 10 cm of silica was scraped from the 
plate and the lipids were re-extracted from the silica and 
applied to a preparative TLC plate (1 mm thick). The 
plate was developed in the same solvent and a radioac- 
tive band of silica, corresponding to a phosphatidyl- 
choline standard, was scraped from the plate. The lipids 
were extracted and dried. (No additional phospholipid 
was present on the upper 10 cm of the original TLC 
plate.) 
In order to purify the fenbufenoyl-lipids from the 
non-radioactive natural phospholipids that copurified 
on the silica gel, the putative fenbufenoyl-phosphatidyl- 
choline was subjected to high performance liquid chro- 
matography (HPLC) using a reverse phase column to 
separate components of the mixture on the basis of their 
fatty acid composition. Lipid was dissolved in metha- 
nol-acetonitrile-water 70: 15: 15 (v/v) and applied to a 
Beckman Ultrasphere ODS 5 pm 4.6 mm x 35 cm 
column. The column was eluted at 2 ml/min in metha- 
nol-acetonitrile-water 70: 15: 15 (v/v) for 5 min followed 
by a programmed linear gradient changing, over 15 min, 
to 100% methanol in which the elution was continued 
for a final 50 min. Fractions corresponding to peaks of 
radioactivity were collected and used for subsequent 
mass spectroscopic or choline analysis. 
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Mass spectroscopy 
Liquid secondary mass spectra of putative fenbufenoyl- 
phosphatidylcholine were obtained using a VG70- 
250SEQ hybrid mass spectrometer equipped with a Cs' 
gun operating at a primary ion beam of 30 kV. The Cs' 
ions were allowed to bombard the sample dissolved in 
a matrix containing a mixture of dithiothreitol and 
dithioerythritol (3: 1, w/w). Mass spectroscopy/mass 
spectroscopy (MS/MS) studies were performed by mass- 
selecting positive ions from the magnetic analyzer and 
allowing them to collide with neutral Ar atoms (pressure 
2 x torr) present in the first quadrupole at a collision 
energy of 30 eV followed by the mass analysis with the 
second quadrupole. 
Other methods 
Choline was measured by the method of Pomfret et 
al. (24). Data were analyzed by a paired Student's t-test. 
F F-TG - FG - 
RESULTS 
Incorporation into neutral lipid 
Five days after differentiation, 3T3-Ll adipocytes 
were incubated with [14C]fenbufen for 18 h. During the 
incubation, 20.1 k 5.7% (mean k SD of 54 measurements 
in three independent experiments) of the fenbufen 
L I 
0 4 8 12 16 20 
Position on plate (cm) 
Fig. 1. TLC analysis of lipids from cells incubated with fenbufen. 
Cells were incubated for 18 h with [Wlfenbufen, washed, extracted, 
and subjected to TLC in Solvent System 1 as described in Experimental 
Procedures. The TLC plate was scanned using the BioScan 200 and 
the resultant trace is shown. The position of genuine standards as seen 
by staining in I2 are indicated by: PL, mixed phospholipid standards; 
MO, monooleoylglycerol; OA, oleic acid; DO, dioleoylglycerol; TO, 
trioleoylglycerol; FG, (mono)fenbufenoylglycerol; F, fenbufen; F-TC, 
sn-l,3dipalmitoyl-2-fenbufenoyl-glycerol. The position of the origin 
and the solvent front (Sf) are indicated by arrows. The full vertical 
scale represents 5000 counts accumulated by the BioScan 200 over 20 
min. 
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Fig. 2. Digestion of fenoufen-containing triacylglycerol with pancre- 
atic lipase. The band corresponding to fenbufenoyl triacylglycerol was 
scraped from TLC plates and digested with pancreatic lipase for 1 min 
or 40 min as described in Experimental Procedures. The traces from 
the BioScan 200 of subsequent rechromatography in Solvent System 
1 are shown. The full vertical scale represents 3000 counts accumu- 
lated by the BioScan 200 over 15 min. The genuine standards are as 
described under Fig. 1. 
radioactivity was taken up from the medium. Most of 
the label was recovered in the chloroform phase of the 
washed and extracted cells: only 1.63 f 0.35% (n = 54) 
remained in the aqueous phase. When the chloroform 
extract was chromatographed in Solvent System 1, typi- 
cally 94% migrated between the fenbufen standard and 
the solvent front. The major portion cochromatogra- 
phed with a sn-l,3dipalmitoyl-2-fenbufenoyl-glycerol 
standard. Radiolabeled spots running between that 
standard and fenbufen were tentatively identified as 
diacylglycerol analogues, but triacylglycerol analogues 
containing more than one fenbufen moiety could not 
be excluded. No  particular precautions were taken to 
prevent isomerization of diacylglycerols during extrac- 
tion and analysis (20); consequently, the radioactive 
spots corresponding to sn-l,2(2,3-)diacylglycerol (hav- 
ing the lower RJ) and sn-1 ,3-diacylglycerol were com- 
bined as total diacylglycerol for most purposes. Less 
than 1% of the radioactivity coihromatographed with 
fenbufen, but 5.56 f 0.96% (9 observations) was rou- 
tinely associated with more than one component in the 
first cm of the plate where phospholipid standards were 
also located (Fig. 1). 
To confirm the composition of the putative fen- 
bufenoyl-TG, the band was extracted from the silica, 
treated with pancreatic lipase, and resubjected to TLC. 
The fraction corresponding to the fenbufenoyl-TG 
standard decreased from 80% after incubation for 1 min 
to 32% after 40 min of incubation with pancreatic lipase. 
During this time, unesterified fenbufen rose from 13% 
to 40% of the radioactivity and the region correspond- 
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Fig. 3. TLC analysis of putative fenbufen-containing phospholipids. Lipids extracted from cells incubated with fenbufen were subjected to TLC 
in (A) Solvent System 3 (acidic), (B) Solvent System 4 (acidic, more polar), (C) Solvent System 5 (basic), or (D) Solvent System 6 (basic, more 
polar) to separate the phospholipids present. The traces from the BioScan are shown. The position of genuine standards as seen by staining in 
IS or by quenching of the fluorescent indicator at 254 nm are indicated by: NL, neutral lipids (mone, di-, and tri-oleoylglycerol); PE, 
phosphatidylethanolamine: F-PC, synthetic fenbufenoyl-phosphatidylcholine; PC, phosphatidylcholine; PI, phosphatidylinositol; PG, phospha- 
tidylglycerol. Other abbreviations are as Fig. 1. The full vertical scale represents 150 counts accumulated by the BioScan 200 over 30 min (A), 
400 counts over 120 min (B), 150 counts over 30 min (C), or 400 counts over 120 min (D). 
ing to the sn-2-monofenbufenoyl-glycerol standard in- 
creased from 4% to 23% (Fig. 2). 
The possibility could not be ruled out that some of 
the ethanol added as solvent (about 55 FM in the incu- 
bations) reacted with fenbufen forming an ethyl ester 
that may have contributed to the product and have 
migrated with triacylglycerol on TLC; however, quanti- 
tatively and qualitatively similar results were obtained 
when acetonitrile was used instead as the solvent for 
fenbufen (data not shown). 
Incorporation of fenbufen into phospholipid 
In order to identify the radiolabeled products that 
migrated near the origin, samples of the chloroform 
phase were chromatographed in acidic (Solvent System 
3 on Analtech plates and Systems 3 or 4 on Merck plates) 
or basic solvent systems (Solvent System 5 on Analtech 
plates and Systems 5 or 6 on Merck plates). In Solvent 
System 3, neutral lipids, including fenbufen, ran at the 
solvent front. The largest of three other bands migrated 
slightly behind a dioleoylphosphatidylcholine standard. 
On the Merck plates, in either System 3 or 4, this band, 
which again migrated slightly behind the dioleoylphos- 
phatidylcholine standard, exactly cochromatographed 
with the synthetic fenbufenoyl-phosphatidylcholine 
(Fig. 3A and B respectively). One of the other radiola- 
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beled bands was tentatively identified as fenbufenoyl- 
phosphatidylethanolamine. In Solvent Systems 5 and 6 
on the Merck plates, (Fig. 3C and D respectively) the 
major non-neutral radiolabeled compound again mi- 
grated with the fenbufenoyl-phosphatidylcholine stand- 
ard and slightly behind the dioleoylphosphatidylcholine 
standard. A less radioactive band migrated close to the 
phosphatidylethanolamine standard. The basic nature 
of these solvent systems greatly retards the migration of 
acidic phospholipids relative to phosphatidylcholine 
and phosphatidylethanolamine and reduces the likeli- 
hood of their being confused on the TLC plates. Extra 
standards used with the Analtech plates (not shown) 
revealed that no radioactivity comigrated with phospha- 
tidic acid, phosphatidylserine, or sphingomyelin in Sol- 
vent System 5. Furthermore, the two radioactive peaks 
in Solvent System 5 (Fig. 3C), corresponding to stand- 
ards for phosphatidylcholine and phosphatidylethano- 
lamine, were separated further in the earlier run on the 
less active Analtech plates, showing clearly that the 
unesterified fenbufen standard, which migrated be- 
tween the two peaks, was not associated with any radio- 
activity. In an additional TLC analysis, a Merck plate was 
developed first in Solvent System 4 and then in Solvent 
System 6 in the perpendicular direction to give a two-di- 
mensional separation. There were three regions of ra- 
dioactivity not associated with neutral lipid: the one that 
corresponded to the fenbufenoyl-phosphatidylcholine 
standards contained 3.3% of the total radioactivity and 
the one that behaved as phosphatidylethanolamine con- 
tained 1.6%. 
In order to characterize further the product tenta- 
tively identified as fenbufenoyl-phosphatidylcholine, a 
larger amount of material was prepared and purified by 
TLC as described in Experimental Procedures. In an 
attempt to purify the fenbufenoyl product away from 
the (non-radiolabeled) natural phosphatidylcholines, we 
used reverse phase HPLC, which separates lipid species 
according to their fatty acid content (Fig. 4). Five radio- 
active peaks eluted between 14 and 23 min; natural 
phosphatidylcholine standards (dipalmitoyl-, dioleoyl-, 
and dilinoleoyl-) eluted after 25 min. The shorter elution 
time on the hydrophobic column is consistent with the 
presence of the more polar fenbufen in the structure. 
The presence of several peaks probably resulted from 
the presence of a variety of natural fatty acids in the 
remaining position. Two fractions were collected, one 
contained peaks with retention times between 14 and 
18 min (peak 17) and the other between 18 and 22 min 
(peak 19). An additional radioactive peak eluted at about 
2.5 min (called peak 2) close to the solvent front. This 
peak, which contained choline, remains enigmatic. 
The amount of choline in peaks 2, 17, and 19 ex- 
ceeded that predicted by the content of fenbufen-de- 
rived radioactivity (assuming one xenobiotic moiety per 
molecule of phosphatidylcholine) by a factor of 3.5 for 
peak 2,12.5 for peak 17, and 15 for peak 19. Apparently, 
despite the HPLC purification step, the fractions still 
contained considerable quantities of naturally occurring 
choline-containing molecules. 
Contamination of the putative fenbufenoyl-phospha- 
tidylcholine with large amounts of natural phosphatidyl- 
choline renders interpretation of mass spectra problem- 
atic. Two features further complicated the interpre- 
Time (min) 
Fig. 4. Analysis of fenbufencontaining phosphatidylcholine by reverse-phase HPLC. The extracted cellular 
lipid that cochromatographed with phosphatidylcholine was collected from a preparative TLC plate and 
analyzed by HPLC as described in Experimental Procedures. The upper trace shows the output from the UV 
monitor; the lower trace shows the output from the radio-detector with the full scale representing 6200 dpm. 
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Fig. 5. Effect of insulin and isoproterenol on fenbufen release from 3TSL1 cells. 3T3L1 adipocytes were incubated with [I4C]fenbufen for 18 h. 
Medium was removed and cells were washed four times with 1 ml phosphate-buffered saline containing 1% bovine serum albumin. Cells were 
either extracted as described in Experimental Procedures or incubated for up to 2 h with 2 ml culture medium containing 50 ~ L M  non-radioactive 
fenbufen in 5 pl ethanol (the ‘chase medium’) plus either 10 p~ (&)-isoproterenol (A), 10 pg insulin/ml (W), or with no addition (0). At the 
indicated intervals the chase medium was collected and the cells were washed and extracted. Radioactivity associated with the lipid (chloroform) 
phase is shown for (A) cells and (B) media. Points represent the mean f standard deviation for three independent experiments (n = 3 except 
where time = 0: n - 9). Error bars are not shown where they are smaller than the symbol. Control or insulin incubations with results significantly 
different from the isoproterenol incubations are indicated *P < 0.05; **P < 0.01. 
tation: I )  the molecular weight of fenbufen is only two 
less than that of palmitic acid, and 2) in addition to the 
common even-chain fatty acids, 3T3-Ll cells are rich in 
fatty acids with 15 or 17 carbons (25). Nevertheless, it is 
clear that most of the features predicted for fast atom 
bombardment (FAB) mass spectra of phosphatidylchol- 
ines were present (26). Both peak 17 and peak 19 
showed quasi mass ions in the region of 740-770 and a 
major ion at 566. This is close to the position for 
diacylglycero-fragment ions, the major predicted frag- 
ments (26). Peak 17 also showed peaks with m/z = 496 
and 524 that correspond to mono-palmitoyl- and mono- 
stearoylglycerophosphorylcholines, respectively. Fur- 
ther confirmation comes from the MS/MS analysis of 
peak 19 mass ions 746 and 748 which show strong peaks 
at m/z = 184 corresponding to phosphorylcholine. It 
should be noted that peaks 17 and 2 both also showed 
peaks with m/z = 184, although the mass ions were not 
analyzed by MS/MS in these cases because insufficient 
material was available. Direct evidence for phosphatidyl- 
cholines containing fenbufen is more difficult to come 
by, especially as these were shown by choline analysis to 
be minor components. The existence of a distinct peak 
at m/z = 494 suggests the formation of a mono-fen- 
bufenoyl-glycerophosphocholine fragment, but the lack 
of purity means it is possible to find small peaks to match 
almost any predicted product. While these results are 
entirely consistent with the identification of the product 
as a fenbufencontaining phosphatidylcholine, the lack 
of absolute purity means that unequivocal evidence has 
not yet been obtained. 
Hormonestimulated lipolysis of fenbufenylated lipid 
In order to examine the hormone-stimulated metabo- 
lism of the triacylglycerol analogue of fenbufen, differ- 
entiated 3T3-Ll adipocytes were incubated for 18 h with 
27 pM [14C]fenbufen. The cells accumulated 7.06 k 1.05 
nmol/dish from 9 dishes derived from three inde- 
pendent experiments. Seventy-two percent of the 
[“Wlfenbufen was incorporated into a triacylglycerol 
analogue; the remainder migrated as a putative diacyl- 
glycerol analogue (22%) or as phospholipid (6%). Non- 
esterified fenbufen and mono-fenbufenoyl-glycerol rep- 
resented minor constituents (1%). These conditions 
provided cells that were loaded with sufficient fenbufen- 
containing triacylglycerol to enable studies of its further 
metabolism. Cells were then incubated in a chase me- 
dium containing 50 p~ non-radioactive fenbufen to 
dilute any released radioactive fenbufen and reduce the 
likelihood of its reincorporation. (Measurement of ra- 
dioactive fenbufen in the medium can therefore be 
regarded as total, and not as net, release). The amount 
of radiolabel associated with the cells decreased in a 
timedependent manner (Fig. 5A) and there was a con- 
comitant increase in the radioactivity released into the 
medium (Fig. 5B). During the first hour of the chase 
period, fenbufen was released at a rate that was close to 
first order. The rates of release into the medium or loss 
from the cells were 0.81 f 0.22 and 1.12 f 0.48 
nmol/dish per h, respectively. The rates measured in 
the presence of insulin (0.77 k 0.22 and 0.87 f 1.05 
nmol/dish per h appearing in the medium or lost from 
the cells, respectively) were not significantly different (P 
? 0.05). When isoproterenol was present, however, these 
rates increased to 2.04 k 0.11 and 2.5 1 f 0.24 nmol/ dish 
per h appearing in the medium or lost from the cells, 
respectively. The rates measured in the presence of 
isoproterenol were significantly higher than those meas- 
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Fig. 6. Composition of fenbufenoyl-lipids extracted from 3T3-LI cells. Cellular lipids from the experiment described under Fig. 5 were analyzed 
by TLC as described under Experimental Procedures for (A) control, (B) insulin, and (C) isoproterenol. The symbols represent the 
fenbufenderived radioactivity associated with triacylglycerol (O), diacylglycerol (m), or phospholipid (A). Points represent the mean f standard 
error of the mean for three independent experiments (n = 3 except where time = 0: n = 9). Error bars are not shown where they are smaller than 
the symbol. 
ured for the control medium (P < O.Ol), control cells (P 
< 0.05), and insulin medium (P < 0.01). A more kineti- 
cally valid method of analysis is to fit an exponential 
expression to the above time courses and thereby to 
derive a decay constant and halflife (t112) for the intra- 
cellular fenbufen, a measure that is independent of the 
original amount incorporated. The data in Fig. 5B give 
half-life values of 299 min for the control incubations 
changing to 146 min in the presence of isoproterenol 
and to 343 min in the presence of insulin. 
Figure 6 and Figure 7 show the composition of lipid 
products extracted from the cells and the media, respec- 
tively, during the course of the chase experiments. The 
percentage data, used to compile Fig. 6, show that the 
relative amounts of the different fenbufenoyl-lipids re- 
maining in the cells were altered by neither the length 
of the chase period nor by the presence of isoproterenol 
or insulin. In the chase media, 95.1 k 1.8% (n = 15 at 
times > 0) of the fenbufen-derived radioactivity was 
extracted into chloroform. The major radiolabeled 
products in the medium were nonesterified fenbufen, a 
diacylglycerol analogue, and a monoacylglycerol ana- 
logue (Fig. 7). The monoacylglycerol analogue was usu- 
ally represented by a split peak presumably resulting 
from the isomerization by acyl-migration of either the 
monoacylglycerol itself or of its immediate precursor 
the diacylglycerol. These diacylglycerol and monoacyl- 
glycerol analogues did not result from the release of the 
contents of disrupted cells, as virtually no phospholipid 
or triacylglycerol was present in the media. Radiolabeled 
monoacylglycerol was released most rapidly during the 
first 30 min of the chase; it then fell as a proportion of 
the total label. This effect was most marked in the cells 
treated with isoproterenol. Labeled fenbufen and the 
diacylglycerol analogue were present in roughly equal 
quantities (between 38% and 42% of the total) at all 
times and under all conditions. 
Normally when natural precursors are used, mono- 
and di-acylglycerols are not secreted by adipose cells. In 
order to check whether their formation from fenbufen 
could have been an artifact of the experimental condi- 
tions used, parallel experiments were conducted, label- 
1 .o 
- 5 0.2 
0.0 
A 
0 30 60 90 120 
T i m e  of chase (min) 
0 30 60 90 120 
Tlme of chase (mm) 
0 30 60 90 120 
T i m e  of chase (min) 
Fig. 7. Composition of fenbufenoyl-lipids extracted from 3T3-Ll incubation media. Media lipids from the experiment described under Fig. 5 
were analyzed by TLC as described under Experimental Procedures for (A) control, (B) insulin, and (C) isoproterenol. The symbols represent 
the fenbufenderived radioactivity associated with triacylglycerol (O), diacylglycerol (m), phospholipid (A), non-esterified fenbufen (0), 
monoacylgIycerol(0). Points represent the mean f standard error of the mean for three independent experiments (n = 3 except where time = 
0: n = 9). Error bars are not shown where they are smaller than the symbol. 
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ing 3T3-Ll adipocytes for 18 h with either [14C]oleic acid 
or [14C]fenbufen and then chasing them in the presence 
of 50 pM non-radioactive precursor as described above. 
Despite being present at a lower initial concentration, 
more oleic acid than fenbufen was incorporated into 
lipids with similar proportions forming triacylglycerol 
but a greater proportion (27% vs. 6%) forming phos- 
pholipid. The most important observation was that 92.4 
k 2.5% (9 observations) of the released oleic acid, meas- 
ured under all conditions, was found unesterified in the 
medium (compared to only 44.9 f 2.1% (9) of the 
fenbufen; significantly different, P < 0.001) and that no 
mono- or di-acylglycerol could be detected (compared 
to 14% and 39% respectively for the fenbufen). 
It was necessary to confirm that the TLC bands iden- 
tified as analogues of monoacylglycerol and diacyl- 
glycerol were not acidic metabolites of fenbufen, such 
as biphenyl acetic acid or a hydroxylated acid (27), that 
might have migrated to similar positions. Although 
acidic metabolites might migrate close to mono- or 
di-acylglycerols in an acidic solvent system for nonpolar 
lipids (Solvent System l), they would be unlikely to move 
from the origin in a basic solvent system for nonpolar 
lipids (Solvent System 2). Accordingly, an extract of 
chase medium was analyzed by TLC in both Solvent 
Systems 1 (acidic) and 2 (basic). In Solvent System 1, 
fenbufen and biphenyl acetic acid standards both mi- 
grated to the same position on the plate, together with 
33.6% of the radioactivity; in Solvent System 2, both 
acids and 33.3% of the radioactivity were retarded on 
the origin. As hydroxy acids are more polar than fen- 
bufen, they would also have remained at the origin. If 
the mono- or di-acylglycerol bands had been contami- 
nated with the acidic metabolites, then the percentage 
of radioactivity co-chromatographing with genuine fen- 
bufen would have increased in the basic system. Conse- 
quently, the remaining 66% of radioactivity on the plate 
can not be attributed to acidic metabolites of fenbufen. 
Further evidence that the band identified as monofen- 
bufenoyl-glycerol was assigned correctly was obtained by 
incubating it with palmitoyl-CoA and partially purified 
hepatic monoacylglycerol acyltransferase. Very little of 
the radioactive precursor extracted into the heptane 
phase but, after incubation for 60 min, 97% of the 
heptaneextractable radioactivity chromatographed in 
Solvent System 1 ahead of the fenbufen standard and 
below the sn-1,3-dipalmitoyl-2-fenbufenoyl-glycerol 
standard in the area assigned to the diacylglycerol ana- 
logues. The sn-l,2-(2,3-)-diacylglycerol in the product 
exceeded the sn-l,3-diacylglycerol by 60%: this result 
could reflect the isomerization of the precursor, the 
specificity of the enzyme, and the isomerization of the 
product but does suggest that some of the precursor 
monoacylglycerol was in the sn-2 form, particularly since 
hepatic MGAT is highly specific for sn-2-monoacyl- 
glycerols (22). These results both 1) confirm that the 
product identified as the monoacylglycerol analogue 
was a substrate for monoacylglycerol acyltransferase, 
and 2) support the identification of the diacylglycerol 
analogue by TLC. 
DISCUSSION 
Our results show clearly that the nonsteroidal anti-in- 
flammatory drug, fenbufen, is readily taken up from the 
incubation medium by differentiated 3T3-Ll adipocytes 
and incorporated into products analogous to natural 
lipids. 3T3-Ll adipocytes appear not to express the 
detoxication enzymes found in other tissues such as 
liver. Although the formation and subsequent incorpo- 
ration of fenbufen metabolites, such as the chain-short- 
ened biphenyl acetic acid, cannot be ruled out, it is 
unlikely that any of the documented hydroxyderivatives 
(27-29) were formed because they would have been 
evident during the TLC analysis of the products secreted 
into the chase medium. The data did not support the 
formation of the unidentified hydrophilic conjugates 
(27) because less than 5% of the radioactivity in the chase 
media partitioned into the aqueous phase when ex- 
tracted with chloroform-methanol. In contrast, 
biphenyl acetic acid, derived from fenbufen, was formed 
and incorporated into lipids in primary cultures of rat 
hepatocytes and 50% of the radioactivity in these hepa- 
tocytes extracted into the aqueous phase (T. Vrablik, P. 
F. Dodds, and R. A. Coleman, unpublished results). The 
lack of competing detoxication enzymes probably con- 
tributes to the relatively high rate of incorporation of 
fenbufen by 3T3-Ll cells. The presence of a karbon 
aliphatic moiety at the carboxyl end of fenbufen may 
also make it a good substrate for fatty acid-CoA ligase 
or for the acyltransferases. The identity of the acyltrans- 
ferase or acyltransferases responsible for the incorpora- 
tion of fenbufen into glycerolipids cannot be inferred 
from the present experiments although it is likely that 
both monoacylglycerol acyltransferase and diacyl- 
glycerol acyltransferase contribute (30,31). It will be of 
interest to learn in future experiments whether the 
natural fatty acids and fenbufen compete for ligase or 
acyltransferase active sites. 
This is the first report to show that fenbufen is incor- 
porated into neutral lipids and to provide good evidence 
that an acid with aromatic groups close to the carboxylic 
acid moiety can be incorporated into phospholipids. 
Previous studies have identified xenobiotic phos- 
pholipids that were formed from acids that either closely 
resembled a natural fatty acid or that were modified only 
at the wend of a long aliphatic chain (32-36). Evidence 
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has not been provided to support the claims that phos- 
pholipids can be formed from the hypoglycemic com- 
pounds tetradecylglycidic acid and 5-tetradecyloxy-2- 
furan carboxylic acid (37,38). Preliminary reports from 
our laboratory have suggested that hepatocytes can 
synthesize phospholipids that contain 3-phenoxyben- 
zoic acid or ibuprofen (39). The evidence presented here 
(behavior in a variety of different TLC systems using 
genuine synthetic fenbufenoyl-phosphatidylcholine as a 
standard, behavior on reverse-phase HPLC, choline 
analysis, and mass spectroscopy) strongly suggest that 
several molecular species of fenbufenoyl-phosphatidyl- 
choline were formed. In addition, fenbufenoyl-phos- 
pholipids of two other classes were formed, one of which 
behaved similarly to phosphatidylethanolamine on 
chromatography. To be unambiguously identified, 
these products will require mass spectral analysis after 
they have been purified away from all natural counter- 
parts. 
The chase experiments indicate that radioactivity 
from fenbufen can be released from 3T3-Ll adipocytes 
and that isoproterenol, a Ps-adrenergic receptor agonist, 
stimulates release about threefold. Insulin, under the 
conditions used, did not inhibit the release of either 
[I4C]oleate or [ 14C]fenbufen into the medium. The con- 
centration of insulin used (1.7 pM) was well in excess of 
the 0.1 nM concentration that, in conditions of acute 
exposure, inhibits lipolysis by 50% (25). Insulin probably 
failed to affect the rate of lipolysis in the current experi- 
ments because the cells had been chronically exposed to 
the hormone (17, 18). 
Hormone-sensitive lipase (EC 3.1.1.3), which is re- 
sponsible for the initial steps of lipolysis in adipose tissue 
(40), appeared to be responsible for the increased re- 
lease of fenbufen in response to isoproterenol. Hor- 
mone-sensitive lipase activity has not been measured 
with fenbufenoyl substrates, but we have shown that it 
hydrolyzes dipalmitoyl 3-phenoxybenzoyl glycerols at 
about one-third of the rate observed with tripalmitoyl- 
glycerol and one-tenth of the rate with trioleoylglycerol 
(41). Lipoprotein lipase (EC 3.1.1.34) and pancreatic 
lipase both also have lower activities with xenobiotic 
substrates than with the corresponding ‘natural’ sub- 
strates (1, 6, 11, 13, 41). It also appears that the ester 
bond between the xenobiotic acid and glycerol is selec- 
tively resistant to hydrolysis within a given triacylglycerol 
resulting in diacyl- and monoacyl-glycerols as the princi- 
pal products of lipolysis (13, 41). Relative resistance to 
lipolysis may therefore be responsible for our results. 
Although the secretion rates of the fenbufen-labeled and 
the oleate-labeled lipids were comparable, only 32-43% 
of the fenbufen product in the medium was the non- 
esterified acid, and the remainder of the fenbufenoyl- 
product was released as mono- and di-acylglycerols (Fig. 
7). In contrast, more than 90% of the label released by 
the oleate-labeled cells was oleic acid. 
The appearance in the medium of monofenbufenoyl- 
glycerol and a fenbufenoyl-containing diacylglycerol 
raises some interesting questions. With natural triacyl- 
glycerols, the products secreted by adipose tissue are 
fatty acids and glycerol; apart from the secretion of 
monobutanoylglycerol(42), partial acylglycerols do not 
appear to be released, probably because they are good 
substrates for both hormone-sensitive lipase and 
monoacylglycerol lipase. Our work suggests that, when 
they are present in sufficient concentrations, acyl- 
glycerols can be transported out of the cell. If xenobiotic 
analogues of monoacyl- and diacyl-glycerols are also 
secreted in vivo, the fate of these products may have 
particular importance in view of the evidence that at 
least one xenobiotic analogue of sn-l,2-diacylglycerol 
stimulates protein kinase C in a manner similar to that 
of tumor-promoting phorbol diesters (6). 
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